Description
| Product Name | Details | CAT.No | Size |
| Direct HDL | Suitable for CA 180/270/400 Furuno/ Daytona Series Reagents | BXCF421A | R1: 3 x 51ml R2: 3 x 20ml |
Product Description
The Biorex Diagnostics Direct HDL Assay is an in vitro diagnostic test for the quantitative determination of high-density lipoprotein cholesterol in human serum and plasma. High-density lipoprotein cholesterol plays a pivotal role in lipid metabolism by mediating reverse cholesterol transport, carrying excess cholesterol from peripheral tissues to the liver for elimination. Its measurement is a key component of cardiovascular risk assessment, making this assay an essential tool for clinical laboratories, hospital diagnostics, and research studies focused on metabolic and heart health.
This assay uses a direct enzymatic method, allowing precise measurement without interference from low-density lipoproteins, very-low-density lipoproteins, or other plasma components. By minimizing cross-reactivity, the Biorex Direct HDL Assay ensures reproducible results across diverse patient populations, including individuals with mixed dyslipidemia or elevated triglycerides. Reliable measurement supports the accurate evaluation of lipid profiles, enabling clinicians to make informed decisions on preventive strategies, treatment planning, and long-term patient care.
Key Features
• Direct quantification of high-density lipoprotein cholesterol in serum and plasma
• Sensitive marker for cardiovascular health and lipid metabolism
• Eliminates interference from LDL, VLDL, and other plasma lipoproteins
• Enzymatic method provides high precision and reproducibility
• Compatible with CA 180/270/400 Furuno/Daytona analyzers
• Supports routine lipid panel testing, preventive screenings, and therapeutic monitoring
Benefits
The Biorex Direct HDL Assay provides reliable and clinically meaningful data for cardiovascular risk evaluation and lipid disorder management. Its accuracy and reproducibility allow laboratories to detect subtle changes in lipoprotein levels, assisting in monitoring patients with hyperlipidemia, metabolic syndrome, or other lipid-related disorders. Automated analyzer compatibility reduces preparation time, increases throughput, and ensures consistent results.
Incorporating this assay into routine laboratory workflows helps clinicians monitor treatment efficacy and evaluate patient response over time. Accurate measurement of high-density lipoprotein cholesterol contributes to comprehensive cardiovascular risk profiling, supports early detection of potential heart disease, and aids preventative care strategies. This assay is a high-quality, dependable solution for laboratories committed to precision, reproducibility, and patient-centered cardiovascular assessment.
Contact Us for further product information and technical support.